Icecure Medical Ltd [ICCM] stock prices are down -3.57% to $1.08 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ICCM shares have gain 6.93% over the last week, with a monthly amount glided 6.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Icecure Medical Ltd [ICCM] has been fluctuating between $0.47 and $1.63 over the past year. Currently, Wall Street analysts expect the stock to reach $2.38 within the next 12 months. Icecure Medical Ltd [NASDAQ: ICCM] shares were valued at $1.08 at the most recent close of the market. An investor can expect a potential return of 120.37% based on the average ICCM price forecast.
Analyzing the ICCM fundamentals
The Icecure Medical Ltd [NASDAQ:ICCM] reported sales of 2.79M for trailing twelve months, representing a drop of -48.07%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -5.69%, Pretax Profit Margin comes in at -5.59%, and Net Profit Margin reading is -5.59%. To continue investigating profitability, this company’s Return on Assets is posted at -1.47, Equity is -2.41 and Total Capital is -5.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.82.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0238 points at the first support level, and at 0.9675 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1225, and for the 2nd resistance point, it is at 1.1649.
Ratios To Look Out For
It’s worth pointing out that Icecure Medical Ltd [NASDAQ:ICCM]’s Current Ratio is 1.18. As well, the Quick Ratio is 0.88, while the Cash Ratio is 0.7. Considering the valuation of this stock, the price to sales ratio is 26.59, the price to book ratio is 21.93.
